Research progress on risk factors for poor prognosis in pediatric non-esophageal eosinophilic gastrointestinal disorder

LIU Xiang-Hui; CHEN Xiu-Qi

doi:10.7499/j.issn.1008-8830.2411034

PDF(542 KB)

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (4) : 493-499. DOI: 10.7499/j.issn.1008-8830.2411034

REVIEW

Research progress on risk factors for poor prognosis in pediatric non-esophageal eosinophilic gastrointestinal disorder

LIU Xiang-Hui

Author information +

History +

Abstract

Non-esophageal eosinophilic gastrointestinal disorder (non-EoE EGID) is a group of immune-mediated gastrointestinal diseases characterized by infiltration of eosinophils. Although most patients experience symptom relief after treatment, some still face the risk of persistent symptoms or relapse. Improving the prognosis for this subset of patients remains an urgent challenge. Identifying risk factors that affect the prognosis of non-EoE EGID and providing timely effective interventions are crucial for improving outcomes. This paper reviews the risk factors related to the prognosis of pediatric non-EoE EGID, including genetic factors, allergies, environmental factors, clinical characteristics, endoscopic findings, and pathological manifestations, with the aim of providing references for clinical decision-making.

Key words

Eosinophilic gastrointestinal disorder / Prognosis / Risk factor / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIU Xiang-Hui,CHEN Xiu-Qi. Research progress on risk factors for poor prognosis in pediatric non-esophageal eosinophilic gastrointestinal disorder[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(4): 493-499 https://doi.org/10.7499/j.issn.1008-8830.2411034

References

1 Dellon ES, Gonsalves N, Abonia JP, et al. International consensus recommendations for eosinophilic gastrointestinal disease nomenclature[J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2474-2484.e3. PMID: 35181570. PMCID: PMC9378753. DOI: 10.1016/j.cgh.2022.02.017.
2 Jensen ET, Martin CF, Kappelman MD, et al. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database[J]. J Pediatr Gastroenterol Nutr, 2016, 62(1): 36-42. PMID: 25988554. PMCID: PMC4654708. DOI: 10.1097/MPG.0000000000000865.
3 Licari A, Votto M, Scudeller L, et al. Epidemiology of nonesophageal eosinophilic gastrointestinal diseases in symptomatic patients: a systematic review and meta-analysis[J]. J Allergy Clin Immunol Pract, 2020, 8(6): 1994-2003.e2. PMID: 32061717. DOI: 10.1016/j.jaip.2020.01.060.
4 Ishihara S, Kinoshita Y, Schoepfer A. Eosinophilic esophagitis, eosinophilic gastroenteritis, and eosinophilic colitis: common mechanisms and differences between east and west[J]. Inflamm Intest Dis, 2016, 1(2): 63-69. PMID: 29922659. PMCID: PMC5988173. DOI: 10.1159/000445131.
5 Papadopoulou A, Amil-Dias J, Auth MK, et al. Joint ESPGHAN/NASPGHAN guidelines on childhood eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis[J]. J Pediatr Gastroenterol Nutr, 2024, 78(1): 122-152. PMID: 38291684. DOI: 10.1097/MPG.0000000000003877.
6 Pineton de Chambrun G, Gonzalez F, Canva JY, et al. Natural history of eosinophilic gastroenteritis[J]. Clin Gastroenterol Hepatol, 2011, 9(11): 950-956.e1. PMID: 21806952. DOI: 10.1016/j.cgh.2011.07.017.
7 郝建云, 钟雪梅, 朱丹, 等. 儿童嗜酸细胞性胃肠炎30例临床分析[J]. 中华实用诊断与治疗杂志, 2020, 34(5): 477-479. DOI: 10.13507/j.issn.1674-3474.2020.05.013.
8 龙云, 王震, 梅少华, 等. 儿童嗜酸性粒细胞性胃肠炎22例病例系列报告[J]. 中国循证儿科杂志, 2020, 15(5): 356-360. DOI: 10.3969/j.issn.1673-5501.2020.05.006.
9 Li KW, Ruan GC, Liu S, et al. Long-term prognosis and its associated predictive factors in patients with eosinophilic gastroenteritis[J]. World J Gastroenterol, 2024, 30(2): 146-157. PMID: 38312116. PMCID: PMC10835522. DOI: 10.3748/wjg.v30.i2.146.
10 Allen-Brady K, Colletier KJ, Woller S, et al. Eosinophilic gastritis and enteritis are increased in families with eosinophilic esophagitis[J]. Am J Gastroenterol, 2023, 118(2): 263-268. PMID: 36148824. PMCID: PMC9898099. DOI: 10.14309/ajg.0000000000002021.
11 Zadeh-Esmaeel MM, Rezaei-Tavirani M, Ali Ahmadi N, et al. Evaluation of gene expression change in eosinophilic gastroenteritis[J]. Gastroenterol Hepatol Bed Bench, 2019, 12(3): 239-245. PMID: 31528308. PMCID: PMC6668767.
12 Zhang J, Hou S, Chi XQ, et al. Role of SNAP25 on the occurrence and development of eosinophilic gastritis[J]. Medicine (Baltimore), 2023, 102(29): e34377. PMID: 37478220. PMCID: PMC10662829. DOI: 10.1097/MD.0000000000034377.
13 Low EE, Dellon ES. Review article: emerging insights into the epidemiology, pathophysiology, diagnostic and therapeutic aspects of eosinophilic oesophagitis and other eosinophilic gastrointestinal diseases[J]. Aliment Pharmacol Ther, 2024, 59(3): 322-340. PMID: 38135920. PMCID: PMC10843587. DOI: 10.1111/apt.17845.
14 Nagashima S, Yamamoto M, Inuzuka Y, et al. Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis[J]. Allergol Int, 2023, 72(2): 306-315. PMID: 36414511. DOI: 10.1016/j.alit.2022.11.001.
15 Higuchi T, Tokunaga M, Murai T, et al. Elemental diet therapy for eosinophilic gastroenteritis and dietary habits[J]. Pediatr Int, 2022, 64(1): e14894. PMID: 34157188. DOI: 10.1111/ped.14894.
16 Lucendo AJ, Serrano-Montalbán B, Arias á, et al. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis[J]. J Pediatr Gastroenterol Nutr, 2015, 61(1): 56-64. PMID: 25699593. DOI: 10.1097/MPG.0000000000000766.
17 Ko HM, Morotti RA, Yershov O, et al. Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy[J]. Am J Gastroenterol, 2014, 109(8): 1277-1285. PMID: 24957155. DOI: 10.1038/ajg.2014.166.
18 Sato H, Honma T, Owaki T, et al. Clinical and pathological profile of eosinophilic gastroenteritis[J]. Eur J Gastroenterol Hepatol, 2019, 31(2): 157-162. PMID: 30113369. DOI: 10.1097/MEG.0000000000001241.
19 Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(3): 146-156. PMID: 20125092. DOI: 10.1038/nrgastro.2010.5.
20 Janssens J, Vanuytsel T. Non-esophageal eosinophilic gastrointestinal diseases: a narrative review[J]. Acta Gastroenterol Belg, 2023, 86(3): 449-459. PMID: 37814561. DOI: 10.51821/86.3.11869.
21 李婧, 吴捷, 王天有. 嗜酸细胞性胃肠道疾病的发病机制研究进展[J]. 国际儿科学杂志, 2023, 50(3): 190-194. DOI: 10.3760/cma.j.issn.1673-4408.2023.03.011.
22 Shoda T, Wen T, Caldwell JM, et al. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study[J]. J Allergy Clin Immunol, 2020, 145(1): 255-269. PMID: 31738990. PMCID: PMC6949389. DOI: 10.1016/j.jaci.2019.11.007.
23 Ben-Baruch Morgenstern N, Shoda T, Rochman Y, et al. Local type 2 immunity in eosinophilic gastritis[J]. J Allergy Clin Immunol, 2023, 152(1): 136-144. PMID: 36754294. PMCID: PMC10330288. DOI: 10.1016/j.jaci.2023.01.021.
24 Donald K, Finlay BB. Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease[J]. Nat Rev Immunol, 2023, 23(11): 735-748. PMID: 37138015. DOI: 10.1038/s41577-023-00874-w.
25 Jensen ET, Dai X, Kodroff E, et al. Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases[J]. Clin Res Hepatol Gastroenterol, 2023, 47(7): 102170. PMID: 37352927. PMCID: PMC10529369. DOI: 10.1016/j.clinre.2023.102170.
26 Furuta GT, Fillon SA, Williamson KM, et al. Mucosal microbiota associated with eosinophilic esophagitis and eosinophilic gastritis[J]. J Pediatr Gastroenterol Nutr, 2023, 76(3): 347-354. PMID: 36525669. PMCID: PMC10201396. DOI: 10.1097/MPG.0000000000003685.
27 Kropp DR, Rainville JR, Glover ME, et al. Chronic variable stress leads to sex specific gut microbiome alterations in mice[J]. Brain Behav Immun Health, 2024, 37: 100755. PMID: 38618010. PMCID: PMC11010943. DOI: 10.1016/j.bbih.2024.100755.
28 白娅娅, 唐碧雯, 胡月亮, 等. 71例嗜酸细胞性胃肠炎的临床特征和预后分析[J]. 内科理论与实践, 2023, 18(4): 270-277. DOI: 10.16138/j.1673-6087.2023.04.012.
29 Klein NC, Hargrove RL, Sleisenger MH, et al. Eosinophilic gastroenteritis[J]. Medicine (Baltimore), 1970, 49(4): 299-319. PMID: 5426746. DOI: 10.1097/00005792-197007000-00003.
30 Chang JY, Choung RS, Lee RM, et al. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type[J]. Clin Gastroenterol Hepatol, 2010, 8(8): 669-675; quiz e88. PMID: 20451664. DOI: 10.1016/j.cgh.2010.04.022.
31 Yamamoto M, Nagashima S, Yamada Y, et al. Comparison of nonesophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: a nationwide survey[J]. J Allergy Clin Immunol Pract, 2021, 9(9): 3339-3349.e8. PMID: 34214704. DOI: 10.1016/j.jaip.2021.06.026.
32 Choi BS, Hong SJ, Park SH, et al. Differences in features and course of mucosal type eosinophilic gastroenteritis between Korean infants and children[J]. J Korean Med Sci, 2015, 30(8): 1129-1135. PMID: 26240491. PMCID: PMC4520944. DOI: 10.3346/jkms.2015.30.8.1129.
33 Katz AJ, Twarog FJ, Zeiger RS, et al. Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course[J]. J Allergy Clin Immunol, 1984, 74(1): 72-78. PMID: 6547462. DOI: 10.1016/0091-6749(84)90090-3.
34 Ng LQ, Loh W, Ong JX, et al. Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis[J]. J Paediatr Child Health, 2022, 58(7): 1244-1250. PMID: 35388934. DOI: 10.1111/jpc.15969.
35 Havlichek D, Choung RS, Murray JA. Eosinophilic gastroenteritis: using presenting findings to predict disease course[J]. Clin Transl Gastroenterol, 2021, 12(10): e00394. PMID: 34620754. PMCID: PMC8500667. DOI: 10.14309/ctg.0000000000000394.
36 Votto M, Lenti MV, De Silvestri A, et al. Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features[J]. Ital J Pediatr, 2023, 49(1): 9. PMID: 36647148. PMCID: PMC9841131. DOI: 10.1186/s13052-023-01410-1.
37 Choi JS, Choi SJ, Lee KJ, et al. Clinical manifestations and treatment outcomes of eosinophilic gastroenteritis in children[J]. Pediatr Gastroenterol Hepatol Nutr, 2015, 18(4): 253-260. PMID: 26770900. PMCID: PMC4712538. DOI: 10.5223/pghn.2015.18.4.253.
38 中华医学会变态反应学分会. 2型炎症性疾病机制及靶向治疗专家共识[J]. 中华医学杂志, 2022, 102(42): 3349-3373. DOI: 10.3760/cma.j.cn112137-20220628-01431.
39 张劲松, 邱美慧. 儿童过敏性疾病的心理行为问题[J]. 中华实用儿科临床杂志, 2019, 34(21): 1611-1614. DOI: 10.3760/cma.j.issn.2095-428X.2019.21.003.
40 Taft TH, Carlson DA, Simons M, et al. Esophageal hypervigilance and symptom-specific anxiety in patients with eosinophilic esophagitis[J]. Gastroenterology, 2021, 161(4): 1133-1144. PMID: 34153298. PMCID: PMC8463417. DOI: 10.1053/j.gastro.2021.06.023.
41 Reed CC, Ketchem CJ, Miller TL, et al. Psychiatric comorbidities are highly prevalent in nonesophageal eosinophilic gastrointestinal diseases[J]. Clin Gastroenterol Hepatol, 2022, 20(4): e664-e670. PMID: 34058413. PMCID: PMC8627515. DOI: 10.1016/j.cgh.2021.05.044.
42 Caldwell JM, Collins MH, Stucke EM, et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome[J]. J Allergy Clin Immunol, 2014, 134(5): 1114-1124. PMID: 25234644. PMCID: PMC4254306. DOI: 10.1016/j.jaci.2014.07.026.
43 Greuter T, Katzka D. Endoscopic features of eosinophilic gastrointestinal diseases[J]. Immunol Allergy Clin North Am, 2024, 44(2): 357-368. PMID: 38575229. DOI: 10.1016/j.iac.2024.01.007.
44 李婧, 于飞鸿, 秦秀敏, 等. 儿童嗜酸性粒细胞性胃肠道疾病121例胃镜特点分析[J]. 中国实用儿科杂志, 2024, 39(1): 51-55. DOI: 10.19538/j.ek2024010610.
45 詹春雷, 游洁玉, 李小芹, 等. 267例儿童嗜酸粒细胞性胃肠道疾病临床特征分析: 一项多中心研究[J]. 中国当代儿科杂志, 2024, 26(2): 139-144. PMID: 38436310. PMCID: PMC10921873. DOI: 10.7499/j.issn.1008-8830.2306040.
46 钟雪梅, 马昕, 朱丹, 等. 以中重度贫血为首发表现的儿童嗜酸性粒细胞性胃肠炎6例病例系列报告[J]. 中国循证儿科杂志, 2020, 15(5): 374-377. DOI: 10.3969/j.issn.1673-5501.2020.05.010.
47 任路, 李慧雯, 熊莉娅, 等. 儿童嗜酸性粒细胞性胃肠炎糖皮质激素治疗的预测因素分析[J]. 中国当代儿科杂志, 2021, 23(11): 1149-1153. PMID: 34753547. PMCID: PMC8580022. DOI: 10.7499/j.issn.1008-8830.2108089.
48 Hirano I, Collins MH, King E, et al. Prospective endoscopic activity assessment for eosinophilic gastritis in a multisite cohort[J]. Am J Gastroenterol, 2022, 117(3): 413-423. PMID: 35080202. PMCID: PMC8897269. DOI: 10.14309/ajg.0000000000001625.
49 Grandinetti T, Biedermann L, Bussmann C, et al. Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab[J]. Dig Dis Sci, 2019, 64(8): 2231-2241. PMID: 30982212. DOI: 10.1007/s10620-019-05617-3.
50 Ishihara S, Kuribayashi S, Sato K, et al. A marked eosinophilic infiltration in mucosa could be a better predictive factor for intractable non-esophageal eosinophilic gastrointestinal disorders[J]. Digestion, 2023, 104(5): 348-356. PMID: 37088071. DOI: 10.1159/000528845.
51 Ketchem CJ, Reed CC, Dellon ES. The natural history of eosinophilic gastrointestinal diseases is influenced by age of onset and location of involvement[J]. Am J Gastroenterol, 2024, 119(9): 1813-1820. PMID: 38752626. PMCID: PMC11568073. DOI: 10.14309/ajg.0000000000002869.
52 Hui CK, Hui NK. A prospective study on the prevalence, extent of disease and outcome of eosinophilic gastroenteritis in patients presenting with lower abdominal symptoms[J]. Gut Liver, 2018, 12(3): 288-296. PMID: 29212311. PMCID: PMC5945260. DOI: 10.5009/gnl17056.
53 Shoda T, Rochman M, Collins MH, et al. Molecular analysis of duodenal eosinophilia[J]. J Allergy Clin Immunol, 2023, 151(4): 1027-1039. PMID: 36592704. PMCID: PMC10102870. DOI: 10.1016/j.jaci.2022.12.814.
54 Shoda T, Taylor RJ, Sakai N, et al. Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases[J]. J Allergy Clin Immunol, 2024, 153(6): 1472-1484. PMID: 38555071. PMCID: PMC11162323. DOI: 10.1016/j.jaci.2024.03.013.
55 Olbrich CL, Bivas-Benita M, Xenakis JJ, et al. Remote allergen exposure elicits eosinophil infiltration into allergen nonexposed mucosal organs and primes for allergic inflammation[J]. Mucosal Immunol, 2020, 13(5): 777-787. PMID: 32518365. PMCID: PMC7442625. DOI: 10.1038/s41385-020-0310-x.
56 朱莉, 王颖, 刘沁橘, 等. 儿童非食管嗜酸粒细胞性胃肠道疾病国际联合指南解读[J]. 中华儿科杂志, 2024, 62(7): 625-630. PMID: 38955679. DOI: 10.3760/cma.j.cn112140-20240322-00204.